The Esophagus as an Active Immune Organ

Dr. Vincent Mukkada examining patient John Underhill in the Center for Eosinophilic Disorders.

The Esophagus as an Active Immune Organ

Emerging research reframes the esophagus as a dynamic immune organ, revealing how epithelial barrier function and innate immunity drive esophageal disease beyond inflammation alone.

Refer a Patient

Subspecialist On-Call1-888-987-7997

News and InnovationSubscribe to E-Newsletter

Key Takeaways

Persistent esophageal symptoms may reflect immune dysfunction beyond eosinophil inflammation.
Consider referral when symptom burden persists despite standard anti-inflammatory therapy.
Specialized evaluation can assess epithelial barrier, neuromuscular and immune contributors.
Center‑led research informs care pathways for complex or refractory esophageal disease.

Why Persistent Esophageal Symptoms May Require a New Clinical Lens

Emerging research reframes the esophagus as an active immune organ, an insight with important implications for patients whose symptoms persist despite standard therapies. Decades of investigation now show that esophageal tissue plays a central role in sensing, tolerating and responding to antigenic and biophysical challenges.

Disruptions in these innate immune functions, whether inherited or acquired, are increasingly linked to a spectrum of conditions, including allergic disease, inflammatory disorders, select cancers, eosinophilic esophagitis and other rare esophageal diseases.

Notably, ongoing symptoms despite eosinophil depletion in eosinophilic esophagitis suggest that epithelial barrier dysfunction, neuromuscular changes and immune signaling abnormalities may be primary disease drivers rather than residual inflammation alone. For gastroenterologists, this raises important questions about evaluation pathways when patients fail to respond as expected.

At Cincinnati Children’s, our work continues to challenge traditional views of esophageal disease. Ongoing research aims to clarify how esophageal immune mechanisms contribute to persistent symptoms and how these insights can inform more targeted evaluation and referral for complex cases.

Marc Rothenberg, MD, PhD

What Emerging Esophageal Immunology Means for Clinical Practice

Viewing the esophagus as an active immune organ reshapes how persistent symptoms should be interpreted when standard therapies fall short. Key implications for clinical practice include:

Do not assume persistent symptoms reflect ongoing inflammation alone.
Emerging data indicate that epithelial barrier dysfunction, altered neuromuscular signaling and immune pathway abnormalities may drive symptoms independently of mucosal eosinophilia.
Recognize the limits of histologic remission.
In eosinophilic esophagitis, continued dysphagia or pain despite eosinophil depletion highlights a frequent disconnect between biopsy findings and clinical response, warranting reassessment of disease mechanisms rather than reflex escalation of anti‑inflammatory therapy.
Evaluate topical therapy options.
Another implication of the epithelium as a primary immune organ is the utility of topical therapy (e.g., swallowed glucocorticoids) rather than systemic therapy.
Broaden diagnostic thinking in refractory or atypical cases.
Standard evaluation pathways centered on endoscopy and histology may be insufficient to capture immune-mediated, functional or remodeling-related contributors to disease persistence.
Consider early referral for complex disease phenotypes.
Patients with treatment-resistant or unexplained esophageal disease may benefit from referral to centers with expertise in esophageal immunology and rare disorders, where advanced phenotyping can inform more targeted and individualized management.

Learn when to consider referral for complex or refractory esophageal disease by contacting Cincinnati Center for Eosinophilic Disorders intake at 513-636-7402 or cced@cchmc.org.

(Published April 2026)

Pediatric Subspecialty News and Innovation

Our experts are redefining pediatric care. Showcasing their impact is simple. Discover the leaders behind our programs, the innovations they're driving, and the research shaping tomorrow’s care.

View All Subspecialty News